Vitargent Biotechnology Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series B2
  • Investors
  • 9

Vitargent Biotechnology General Information

Description

Provider of biotechnology and testing services. The company's biotechnology and testing services develops transgenic medaka and zebrafish fish embryo for conducting toxic laboratory tests, enabling industries such as cosmetics, skincare, food and beverage conglomerate to safeguard their products against harmful chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Unit 203, 16 West
  • Number 12 Science Park West Avenue
  • Hong Kong, Hong Kong
  • Hong Kong
+852 2393 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitargent Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B2) 04-Jul-2018 Completed Generating Revenue
4. Later Stage VC (Series B1) 01-Mar-2018 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 26-May-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Jan-2015 Completed Startup
1. Accelerator/Incubator 15-Oct-2010 Completed Startup
To view Vitargent Biotechnology’s complete valuation and funding history, request access »

Vitargent Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biotechnology and testing services. The company's biotechnology and testing services develops transgenic med
Biotechnology
Hong Kong, Hong Kong
5 As of 2015
00000000000

00000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000000000 00000000 (0000000000)
Luxembourg, Luxembourg
00000 As of 0000
00000
000000000 00000

000 000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000000
Saclay, France
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vitargent Biotechnology Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eurofins Scientific Corporation Luxembourg, Luxembourg 00000 00000 000000000 00000
000 000 0000000000 Formerly PE-Backed Saclay, France 000 000000000000
0000000 0000000000 Private Equity-Backed Rensselaer, NY 000 00.000 000000000 00.000
0000000 Venture Capital-Backed Riga, Latvia 0 00000 0000000000 00000
0000000 Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
To view Vitargent Biotechnology’s complete competitors history, request access »

Vitargent Biotechnology Patents

Vitargent Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201811234-D0 Determination of safety grade or score of a product Ceased 09-Jul-2018 000000000
EP-3594887-A1 Computing system and method for determining safety index of product Withdrawn 09-Jul-2018 000000000 0
US-20200013133-A1 Computing system and method for determining safety index of product Pending 09-Jul-2018 000000000
EP-3255430-A1 Toxicant assays for cosmetic products using teleost embryos Granted 08-Jun-2016 00000000000 0
EP-3255430-B1 Toxicant assays for cosmetic products using teleost embryos Active 08-Jun-2016 G01N33/5014
To view Vitargent Biotechnology’s complete patent history, request access »

Vitargent Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Jimmy Tao Chief Executive Officer
Xueping Chen Ph.D Co-Founder, Chief Technology Officer & Director
Eric Chen Co-Founder, Chief Commercial Officer & Director
Jeffrey Cheung Co-Founder, Chief Financial Officer & Director, Corporate Service
You’re viewing 4 of 5 executive team members. Get the full list »

Vitargent Biotechnology Board Members (1)

Name Representing Role Since
Peter Liu WI Harper Group Chairman 000 0000
To view Vitargent Biotechnology’s complete board members history, request access »

Vitargent Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitargent Biotechnology Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bridgefield Capital Management PE/Buyout Minority 000 0000 000000 0
HeungKong Group Limited Corporation Minority 000 0000 000000 0
Leohe Capital Venture Capital Minority 000 0000 000000 0
PwC China Accelerator/Incubator Minority 000 0000 000000 0
Innoangel Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »